• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强基因传递至中枢神经系统的策略。

Strategies for enhanced gene delivery to the central nervous system.

作者信息

Gao Zhenghong

机构信息

Mechanical Engineering, The University of Texas at Dallas USA

出版信息

Nanoscale Adv. 2024 Apr 25;6(12):3009-3028. doi: 10.1039/d3na01125a. eCollection 2024 Jun 11.

DOI:10.1039/d3na01125a
PMID:38868835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11166101/
Abstract

The delivery of genes to the central nervous system (CNS) has been a persistent challenge due to various biological barriers. The blood-brain barrier (BBB), in particular, hampers the access of systemically injected drugs to parenchymal cells, allowing only a minimal percentage (<1%) to pass through. Recent scientific insights highlight the crucial role of the extracellular space (ECS) in governing drug diffusion. Taking into account advancements in vectors, techniques, and knowledge, the discussion will center on the most notable vectors utilized for gene delivery to the CNS. This review will explore the influence of the ECS - a dynamically regulated barrier-on drug diffusion. Furthermore, we will underscore the significance of employing remote-control technologies to facilitate BBB traversal and modulate the ECS. Given the rapid progress in gene editing, our discussion will also encompass the latest advances focused on delivering therapeutic editing to the CNS tissue. In the end, a brief summary on the impact of Artificial Intelligence (AI)/Machine Learning (ML), ultrasmall, soft endovascular robots, and high-resolution endovascular cameras on improving the gene delivery to the CNS will be provided.

摘要

由于各种生物屏障的存在,将基因递送至中枢神经系统(CNS)一直是一项持续存在的挑战。尤其是血脑屏障(BBB),它阻碍了全身注射药物进入实质细胞,仅有极小比例(<1%)的药物能够通过。最近的科学见解突出了细胞外空间(ECS)在控制药物扩散方面的关键作用。考虑到载体、技术和知识的进步,讨论将聚焦于用于向中枢神经系统进行基因递送的最显著载体。本综述将探讨ECS(一种动态调节的屏障)对药物扩散的影响。此外,我们将强调采用远程控制技术以促进血脑屏障穿越和调节ECS的重要性。鉴于基因编辑的快速进展,我们的讨论还将涵盖专注于向中枢神经系统组织递送治疗性编辑的最新进展。最后,将简要总结人工智能(AI)/机器学习(ML)、超小型软质血管内机器人和高分辨率血管内摄像头对改善向中枢神经系统进行基因递送的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/e6d2c1b420b4/d3na01125a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/c2c77554135c/d3na01125a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/6549ee7cf942/d3na01125a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/568415ab74b1/d3na01125a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/bb3e61e109eb/d3na01125a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/2f5b7464ab08/d3na01125a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/e6d2c1b420b4/d3na01125a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/c2c77554135c/d3na01125a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/6549ee7cf942/d3na01125a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/568415ab74b1/d3na01125a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/bb3e61e109eb/d3na01125a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/2f5b7464ab08/d3na01125a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d21/11166101/e6d2c1b420b4/d3na01125a-f6.jpg

相似文献

1
Strategies for enhanced gene delivery to the central nervous system.增强基因传递至中枢神经系统的策略。
Nanoscale Adv. 2024 Apr 25;6(12):3009-3028. doi: 10.1039/d3na01125a. eCollection 2024 Jun 11.
2
Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.新兴技术在血脑屏障中传递生物治疗药物和基因治疗的应用
BioDrugs. 2018 Dec;32(6):547-559. doi: 10.1007/s40259-018-0309-y.
3
Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.脑穿透肽和肽药物偶联物克服血脑屏障并靶向中枢神经系统疾病。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1695. doi: 10.1002/wnan.1695. Epub 2021 Jan 20.
4
Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders.血脑屏障(BBB)穿越策略,改善中枢神经系统疾病的治疗。
Handb Exp Pharmacol. 2024;284:213-230. doi: 10.1007/164_2023_689.
5
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.中枢神经系统癌症的细胞和分子靶向药物递送:靶向策略的进展。
Curr Top Med Chem. 2020;20(30):2762-2776. doi: 10.2174/1568026620666200826122402.
6
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment.BBB 穿越型腺相关病毒载体:一种用于 CNS 疾病治疗的优秀基因传递工具。
J Control Release. 2021 May 10;333:129-138. doi: 10.1016/j.jconrel.2021.03.029. Epub 2021 Mar 26.
7
Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.炎症状态下大分子和细胞通过血脑屏障的结构通路。综述。
Histol Histopathol. 2004 Apr;19(2):535-64. doi: 10.14670/HH-19.535.
8
Diffusion of macromolecules in the brain: implications for drug delivery.大分子在脑内的扩散:对药物递送的影响。
Mol Pharm. 2013 May 6;10(5):1492-504. doi: 10.1021/mp300495e. Epub 2013 Jan 31.
9
Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?中枢神经系统屏障部位的转运体:药物递送的障碍还是机遇?
Curr Pharm Des. 2014;20(10):1422-49. doi: 10.2174/13816128113199990463.
10
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier.纳米颗粒作为穿越血脑屏障的强大工具。
CNS Neurol Disord Drug Targets. 2023;22(1):18-26. doi: 10.2174/1871527321666220222092655.

引用本文的文献

1
Development of Brain Permeable Drugs and Novel Strategies to Overcome the Brain Barriers for Treatment Purposes.用于治疗目的的脑渗透性药物的开发及克服血脑屏障的新策略。
Curr Pharm Des. 2025 Apr 21. doi: 10.2174/0113816128386983250410092649.
2
Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders.革新神经免疫学:揭示中枢神经系统疾病中的免疫动力学与治疗创新。
Int J Mol Sci. 2024 Dec 19;25(24):13614. doi: 10.3390/ijms252413614.
3
Human TRPV1 is an efficient thermogenetic actuator for chronic neuromodulation.

本文引用的文献

1
Drug delivery to the central nervous system.药物向中枢神经系统的递送。
Nat Rev Mater. 2022 Apr;7(4):314-331. doi: 10.1038/s41578-021-00394-w. Epub 2021 Dec 3.
2
Dexterous helical magnetic robot for improved endovascular access.用于改善血管内进入的灵巧螺旋磁控机器人。
Sci Robot. 2024 Feb 14;9(87):eadh0298. doi: 10.1126/scirobotics.adh0298.
3
Ultrasound Blood-Brain Barrier Opening and Aducanumab in Alzheimer's Disease.超声血脑屏障开放与阿尔茨海默病中的 aducanumab
人类 TRPV1 是一种用于慢性神经调节的高效热原激活器。
Cell Mol Life Sci. 2024 Oct 25;81(1):437. doi: 10.1007/s00018-024-05475-x.
N Engl J Med. 2024 Jan 4;390(1):55-62. doi: 10.1056/NEJMoa2308719.
4
A new age of precision gene therapy.精准基因治疗的新时代。
Lancet. 2024 Feb 10;403(10426):568-582. doi: 10.1016/S0140-6736(23)01952-9. Epub 2023 Nov 22.
5
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies.全身性 AAV 给药后的血栓性微血管病依赖于抗衣壳抗体。
J Clin Invest. 2024 Jan 2;134(1):e173510. doi: 10.1172/JCI173510.
6
Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration.整合的载体基因组可能有助于 AAV 给药后在灵长类动物肝脏中的长期表达。
Nat Biotechnol. 2024 Aug;42(8):1232-1242. doi: 10.1038/s41587-023-01974-7. Epub 2023 Nov 6.
7
Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.用于治疗多发性硬化症的 CNS 的创新药物递送策略。
J Control Release. 2023 Dec;364:435-457. doi: 10.1016/j.jconrel.2023.10.052. Epub 2023 Nov 8.
8
Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs.双特异性抗体穿梭靶向 CD98hc 介导 IgG 高效且持久的脑部递释。
Cell Chem Biol. 2024 Feb 15;31(2):361-372.e8. doi: 10.1016/j.chembiol.2023.09.008. Epub 2023 Oct 26.
9
Hydrogel and Nanomedicine-Based Multimodal Therapeutic Strategies for Spinal Cord Injury.水凝胶和基于纳米医学的多模式脊髓损伤治疗策略。
Small Methods. 2024 Jan;8(1):e2301173. doi: 10.1002/smtd.202301173. Epub 2023 Oct 26.
10
Cerebrospinal fluid analysis of metabolites is not correlated to microdialysis measurements in acute brain injured patients.急性颅脑损伤患者的脑脊液代谢物分析与微透析测量结果不相关。
Clin Neurol Neurosurg. 2023 Nov;234:108011. doi: 10.1016/j.clineuro.2023.108011. Epub 2023 Oct 6.